Skip to content

APOTHEEK CELIS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK CELIS

BE 0432.657.909
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€66,294
2024 · €91,393-€25,099
Equity
€119,438
2024 · €115,644+€3,794
Cash
€169,240
2024 · €96,283+€72,957
Balance sheet total
€371,497
2024 · €291,606+€79,890

Largest movements

2024 to 2025
Assets
  • Cash +€72,957

    up €72,957 (+75.8%), from €96,283 to €169,240

    mainly Other debts (+€80,025) and Net result for the year (+€66,294)

  • Tangible fixed assets +€5,664

    up €5,664 (+390%), from €1,452 to €7,116

Equity and liabilities
  • Other debts +€80,025

    up €80,025 (+65.6%), from €122,017 to €202,042

  • Profit (loss) carried forward +€3,794

    up €3,794 (+9.8%), from €38,562 to €42,356

Income statement
  • Gross operating margin -€14,354

    down €14,354 (-14.3%), from €100,609 to €86,255

  • Financial charges +€8,313

    up €8,313 (+86.7%), from €9,583 to €17,896

  • Financial income -€2,656

    down €2,656 (-62.6%), from €4,241 to €1,585

    of which Non-recurring financial income: -€1,997

  • Other operating charges -€1,223

    down €1,223 (-75.4%), from €1,623 to €400

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €91,393
Gross operating margin -€14,354
Staff costs +€199
Depreciation -€427
Other operating charges +€1,223
Financial income -€2,656
Financial charges -€8,313
Taxes -€771
Result 2025 €66,294
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€142,872
Investment -€7,415
Financing -€62,500
Cash 2024 €96,283
Net result for the year +€66,294
Depreciation +€1,751
Stocks and contracts -€940
Receivables within one year +€2,185
Deferred charges and accrued income -€2,514
Trade debts -€2,771
Other debts +€80,025
Accrued charges and deferred income -€1,158
Investment in fixed assets (net) -€7,415
Contributions, distributions and other -€62,500
Cash 2025 €169,240
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €291,606 €371,497 +€79,890 +27.4%
Fixed assets 21/28 €1,452 €7,116 +€5,664 +390%
Tangible fixed assets 22/27 €1,452 €7,116 +€5,664 +390%
Plant, machinery and equipment 23 €1,452 €7,116 +€5,664 +390%
Current assets 29/58 €290,155 €364,381 +€74,226 +25.6%
Stocks and contracts in progress 3 €101,439 €102,380 +€940 +0.9%
Stocks 30/36 €101,439 €102,380 +€940 +0.9%
Amounts receivable within one year 40/41 €91,400 €89,215 -€2,185 -2.4%
Trade receivables 40 €84,970 €81,658 -€3,312 -3.9%
Other amounts receivable 41 €6,429 €7,556 +€1,127 +17.5%
Cash at bank and in hand 54/58 €96,283 €169,240 +€72,957 +75.8%
Deferred charges and accrued income 490/1 €1,033 €3,547 +€2,514 +243%
Total equity and liabilities 10/49 €291,606 €371,497 +€79,890 +27.4%
Equity 10/15 €115,644 €119,438 +€3,794 +3.3%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €15,082 €15,082 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Tax-exempt reserves 132 €2,975 €2,975 = 0.0%
Distributable reserves 133 €5,907 €5,907 = 0.0%
Profit (loss) carried forward 14 €38,562 €42,356 +€3,794 +9.8%
Amounts payable 17/49 €175,962 €252,058 +€76,096 +43.2%
Amounts payable within one year 42/48 €172,003 €249,257 +€77,254 +44.9%
Trade debts 44 €49,986 €47,215 -€2,771 -5.5%
Suppliers 440/4 €49,986 €47,215 -€2,771 -5.5%
Other amounts payable 47/48 €122,017 €202,042 +€80,025 +65.6%
Accrued charges and deferred income 492/3 €3,959 €2,801 -€1,158 -29.3%
Remuneration, social security and pensions 62 €199 - -€199
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,323 €1,751 +€427 +32.3%
Other operating charges 640/8 €1,623 €400 -€1,223 -75.4%
Gross operating margin 9900 €100,609 €86,255 -€14,354 -14.3%
Operating profit (loss) 9901 €97,464 €84,105 -€13,359 -13.7%
Financial income 75/76B €4,241 €1,585 -€2,656 -62.6%
Recurring financial income 75 €2,244 €1,585 -€659 -29.4%
Non-recurring financial income 76B €1,997 - -€1,997
Financial charges 65/66B €9,583 €17,896 +€8,313 +86.7%
Recurring financial charges 65 €9,583 €17,896 +€8,313 +86.7%
Profit (loss) for the period before taxes 9903 €92,122 €67,794 -€24,328 -26.4%
Income taxes 67/77 €729 €1,500 +€771 +106%
Profit (loss) for the period 9904 €91,393 €66,294 -€25,099 -27.5%
Profit (loss) for the period to be appropriated 9905 €91,393 €66,294 -€25,099 -27.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.